hrcak mascot   Srce   HID

Izvorni znanstveni članak
https://doi.org/10.5599/admet.647

Bioenhancing effects of naringin on atorvastatin

Venkatesh Sama ; G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad-500028, India
Balaraju Pagilla ; G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad-500028, India
Rajeswari Chiluka ; G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad-500028, India
Ravi Alvala ; G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad-500028, India
Ravi Kumar Pola ; G. Pulla Reddy College of Pharmacy, Mehdipatnam, Hyderabad-500028, India
Ramesh Mullangi ; JubilantBiosys, Industrial Suburb, Yeshwanthpur, Bangalore-566022, India

Puni tekst: engleski, pdf (494 KB) str. 174-182 preuzimanja: 115* citiraj
APA 6th Edition
Sama, V., Pagilla, B., Chiluka, R., Alvala, R., Pola, R.K. i Mullangi, R. (2019). Bioenhancing effects of naringin on atorvastatin. ADMET and DMPK, 7 (3), 174-182. https://doi.org/10.5599/admet.647
MLA 8th Edition
Sama, Venkatesh, et al. "Bioenhancing effects of naringin on atorvastatin." ADMET and DMPK, vol. 7, br. 3, 2019, str. 174-182. https://doi.org/10.5599/admet.647. Citirano 15.08.2020.
Chicago 17th Edition
Sama, Venkatesh, Balaraju Pagilla, Rajeswari Chiluka, Ravi Alvala, Ravi Kumar Pola i Ramesh Mullangi. "Bioenhancing effects of naringin on atorvastatin." ADMET and DMPK 7, br. 3 (2019): 174-182. https://doi.org/10.5599/admet.647
Harvard
Sama, V., et al. (2019). 'Bioenhancing effects of naringin on atorvastatin', ADMET and DMPK, 7(3), str. 174-182. https://doi.org/10.5599/admet.647
Vancouver
Sama V, Pagilla B, Chiluka R, Alvala R, Pola RK, Mullangi R. Bioenhancing effects of naringin on atorvastatin. ADMET and DMPK [Internet]. 2019 [pristupljeno 15.08.2020.];7(3):174-182. https://doi.org/10.5599/admet.647
IEEE
V. Sama, B. Pagilla, R. Chiluka, R. Alvala, R.K. Pola i R. Mullangi, "Bioenhancing effects of naringin on atorvastatin", ADMET and DMPK, vol.7, br. 3, str. 174-182, 2019. [Online]. https://doi.org/10.5599/admet.647

Sažetak
Naringin (CAS no: 10236-47-2) is a flavonone glycoside obtained from Citrus paradisi (grapefruit), a natural bioenhancer and reported to enhance the bioavailability of drugs by inhibiting cytochrome P450 and P-glycoprotein (P-gp). The aim of the present study was to investigate the effect of naringin on antihyperlipidemic properties of atorvastatin (AST) in tyloxapol induced hyperlipidemic rats and the effects were supported with measurement of plasma concentrations of AST by HPLC method. Animals received AST along with naringin (15 and 30 mg/kg) shown higher percent reduction in both cholesterol and triglycerides levels, when compared to animals received AST alone at dose of 25 and 50 mg/kg and it was found that the higher percent reduction in cholesterol and triglycerides was proportional to increase in plasma concentration of AST. From the results it is evident that the co-administration of naringin along with AST increased the plasma concentration of AST. The findings of the present study confirmed that naringin could be used as bioenhancer. The co-administration of AST and the diet with naringin (grapefruit) to the patients may potentiate the therapeutic efficacy of AST.

Ključne riječi
Naringin; Bioenhancer; Atorvastatin; Tyloxapol; Plasma concentrations; RP-HPLC

Hrčak ID: 224001

URI
https://hrcak.srce.hr/224001

Posjeta: 221 *